Your browser is no longer supported. Please, upgrade your browser.
Settings
IRIX IRIDEX Corporation daily Stock Chart
IRIX [NASD]
IRIDEX Corporation
Index- P/E258.94 EPS (ttm)0.05 Insider Own4.80% Shs Outstand10.02M Perf Week10.24%
Market Cap121.94M Forward P/E29.68 EPS next Y0.41 Insider Trans-0.41% Shs Float9.37M Perf Month20.02%
Income0.50M PEG8.63 EPS next Q0.04 Inst Own53.80% Short Float0.13% Perf Quarter31.07%
Sales41.80M P/S2.92 EPS this Y-95.20% Inst Trans0.32% Short Ratio0.49 Perf Half Y46.63%
Book/sh3.38 P/B3.60 EPS next Y95.24% ROA1.10% Target Price11.50 Perf Year25.21%
Cash/sh1.00 P/C12.19 EPS next 5Y30.00% ROE1.40% 52W Range6.42 - 11.98 Perf YTD31.00%
Dividend- P/FCF- EPS past 5Y-22.00% ROI- 52W High1.59% Beta0.71
Dividend %- Quick Ratio2.60 Sales past 5Y5.30% Gross Margin47.80% 52W Low89.56% ATR0.37
Employees108 Current Ratio4.10 Sales Q/Q2.50% Oper. Margin0.60% RSI (14)83.56 Volatility3.67% 3.35%
OptionableNo Debt/Eq0.00 EPS Q/Q-94.90% Profit Margin1.10% Rel Volume2.95 Prev Close11.95
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout0.00% Avg Volume24.02K Price12.17
Recom1.00 SMA2015.16% SMA5017.28% SMA20037.70% Volume68,217 Change1.84%
Jan-26-16Initiated Singular Research Buy $11.50
Jan-03-07Initiated First Albany Buy $15.50
May-05-16 07:07AM  Q1 2016 IRIDEX Corp Earnings Release - After Market Close CCBN
Apr-28-16 04:05PM  IRIDEX Announces First Quarter 2016 Conference Call and Release Date PR Newswire
Apr-07-16 01:04PM  IRIDEX CORP Financials
Mar-31-16 05:20PM  IRIDEX CORP Files SEC form 10-K, Annual Report
Mar-22-16 04:31PM  IRIDEX Gains Patent Approvals Covering TxCell-Guided MicroPulse® Laser Therapy; Predictably Enables Faster, Durable Treatments for Glaucoma and Retinal Diseases at noodls
04:05PM  IRIDEX Gains Patent Approvals Covering TxCell-Guided MicroPulse® Laser Therapy; Predictably Enables Faster, Durable Treatments for Glaucoma and Retinal Diseases PR Newswire
Mar-10-16 01:54PM  ETFs with exposure to IRIDEX Corp. : March 10, 2016
Mar-09-16 12:03PM  IRIDEX Corp. :IRIX-US: Earnings Analysis: 2015 By the Numbers
Mar-07-16 05:17PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers
Mar-04-16 02:47PM  Edited Transcript of IRIX earnings conference call or presentation 3-Mar-16 10:00pm GMT
Mar-03-16 05:20PM  Iridex posts 4Q profit
05:03PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:05PM  IRIDEX Reports 2015 Fourth Quarter, Full Year Results PR Newswire
07:07AM  Q4 2015 IRIDEX Corp Earnings Release - After Market Close
Feb-25-16 04:05PM  IRIDEX Announces Fourth Quarter and Full Year 2015 Conference Call and Release Date PR Newswire
Feb-16-16 06:30AM  IRIDEX Receives CE Mark for Cyclo G6 Laser System for the Treatment of Multiple Stages of Glaucoma PR Newswire
Jan-26-16 02:15PM  Coverage initiated on IRIDEX by Singular Research
Jan-12-16 04:04PM  IRIDEX CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-11-16 04:04PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
06:30AM  IRIDEX Announces Preliminary Unaudited Revenues for 2015 Fourth Quarter and Full Year PR Newswire
Jan-08-16 12:00PM  Edited Transcript of IRIX earnings conference call or presentation 5-Nov-15 10:00pm GMT -5.20%
Dec-21-15 12:24PM  IRIDEX Corp. Earnings Analysis: Q3, 2015 By the Numbers
Dec-02-15 08:30AM  Technical Movement Driving Equities - Research on BIND Therapeutics, Edgewater Technology, IRIDEX, and PRGX Global Accesswire
Dec-01-15 05:29PM  Do Hedge Funds Love IRIDEX Corporation (IRIX)? at Insider Monkey
Nov-26-15 07:45AM  Is Biota Pharmaceuticals Inc (BOTA) A Good Stock To Buy? at Insider Monkey
Nov-11-15 06:30AM  IRIDEX to Showcase Cyclo G6 Laser System Equipped with MicroPulse® Tissue Sparing Glaucoma Technology at American Academy of Ophthalmology (AAO) Meeting PR Newswire
Nov-10-15 05:05PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
Nov-05-15 06:48PM  Iridex posts 3Q profit
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:33PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2015 Third Quarter, Nine-Month Results PR Newswire
07:07AM  Q3 2015 IRIDEX Corp Earnings Release - After Market Close
Oct-29-15 04:05PM  IRIDEX Announces Third Quarter 2015 Conference Call and Release Date PR Newswire
Sep-08-15 04:17PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
06:30AM  IRIDEX Broadens Global Glaucoma Outreach With Novel Eye Pressure Diagnostic Device PR Newswire
Aug-26-15 01:56PM  IRIDEX Corp. Earnings Q2, 2015
Aug-20-15 05:01PM  Edited Transcript of IRIX earnings conference call or presentation 6-Aug-15 9:00pm GMT
Aug-12-15 08:12PM  10-Q for IRIDEX Corp. at Company Spotlight
Aug-10-15 05:44PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report -7.02%
Aug-06-15 05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:38PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2015 Second Quarter, Six-Month Results PR Newswire
10:37AM  Novadaq Technologies, Inc. Earnings Q2*, 2015
07:07AM  Q2 2015 IRIDEX Corp Earnings Release - After Market Close
Aug-04-15 04:32PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:05PM  IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity PR Newswire
Jul-30-15 04:05PM  IRIDEX Announces Second Quarter 2015 Conference Call and Release Date PR Newswire
Jul-16-15 07:02AM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -12.00%
06:30AM  IRIDEX Announces Preliminary Revenues for 2015 Second Quarter PR Newswire
Jun-19-15 04:14PM  IRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-18-15 04:13AM  Edited Transcript of IRIX earnings conference call or presentation 7-May-15 9:00pm GMT
May-28-15 04:01PM  IRIDEX to Present at LD Micro Invitational PR Newswire
May-14-15 08:11PM  10-Q for IRIDEX Corp. at Company Spotlight
May-13-15 06:00AM  IRIDEX to Present at UBS Global Healthcare Conference PR Newswire
May-12-15 01:45PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
May-07-15 07:34PM  Iridex posts 1Q profit
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:37PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2015 First Quarter Results PR Newswire
07:07AM  Q1 2015 IRIDEX Corp Earnings Release - After Market Close
Apr-30-15 04:47PM  IRIDEX Announces First Quarter 2015 Conference Call and Release Date at noodls
04:05PM  IRIDEX Announces First Quarter 2015 Conference Call and Release Date PR Newswire
Apr-24-15 08:12PM  10-K for IRIDEX Corp. at Company Spotlight
Apr-16-15 06:30AM  IRIDEX' Total Glaucoma Solution Campaign for US Market to Debut at Annual Congress of the American Society of Cataract and Refractive Surgery PR Newswire +5.02%
Apr-02-15 04:55PM  IRIDEX CORP Files SEC form 10-K, Annual Report
Mar-30-15 06:38AM  IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries at noodls
06:30AM  IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries PR Newswire
Mar-17-15 06:41AM  IRIDEX Announces First Commercial Sales of New Cyclo G6 Glaucoma Laser Systems at noodls
06:30AM  IRIDEX Announces First Commercial Sales of New Cyclo G6 Glaucoma Laser Systems PR Newswire
Mar-09-15 05:13PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers
Mar-05-15 06:31PM  IRIDEX Reports 2014 Fourth Quarter, Year-End Results at noodls -5.75%
06:03PM  Iridex posts 4Q profit
05:00PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:05PM  IRIDEX Reports 2014 Fourth Quarter, Year-End Results PR Newswire
07:07AM  Q4 2014 IRIDEX Corp Earnings Release - Time Not Supplied
Feb-26-15 04:26PM  IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date at noodls
04:05PM  IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date PR Newswire
Feb-23-15 06:30AM  IRIDEX To Debut Cyclo G6 Glaucoma Laser Platform and Present New Clinical Data at the American Glaucoma Society's Annual Meeting PR Newswire
Feb-02-15 06:30AM  IRIDEX Receives FDA Clearance for Cyclo G6 Laser System for the Treatment of Multiple Stages of Glaucoma PR Newswire
Jan-15-15 04:04PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Jan-14-15 06:01AM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Jan-12-15 06:30AM  IRIDEX Announces Preliminary Unaudited Revenues for 2014 Fourth Quarter and Full Year; 2015 Revenue Outlook PR Newswire +6.41%
Dec-31-14 04:12PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Dec-02-14 06:30AM  IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions PR Newswire
Nov-19-14 06:30AM  IRIDEX Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment PR Newswire
Nov-05-14 07:08PM  10-Q for IRIDEX Corp. Company Spotlight
09:11AM  Iridex (IRIX) Upgraded From Hold to Buy at TheStreet
Nov-03-14 02:12PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Oct-30-14 05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today CCBN
04:31PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2014 Third Quarter, Nine-Month Results PR Newswire
07:07AM  Q3 2014 IRIDEX Corp Earnings Release - After Market Close CCBN
Oct-23-14 04:05PM  IRIDEX Announces Third Quarter 2014 Conference Call and Release Date PR Newswire
Oct-17-14 06:30AM  IRIDEX to Host MicroPulse® Worldwide 3-Day Forum at the American Academy of Ophthalmology PR Newswire
Oct-14-14 06:30AM  IRIDEX Expands Retinal Portfolio PR Newswire
Oct-07-14 06:30AM  IRIDEX Granted U.S. Patent for Disposable MicroPulse® Delivery Device for the Non-invasive Treatment of Glaucoma PR Newswire
Oct-01-14 04:05PM  IRIDEX Reports Strong Attendance at European Workshop for its Proprietary MicroPulse® Laser Therapy for Retina and Glaucoma Applications PR Newswire
Sep-26-14 06:02PM  Nasdaq stocks posting largest volume decreases AP
IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as visible (yellow) photocoagulator consoles, visible (Green) photocoagulator consoles, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations; and ophthalmic delivery devices and other products, including TxCell scanning laser delivery systems, TruFocus laser indirect ophthalmoscopes, slit lamp adapters, and operating microscope adapters. Its ophthalmic delivery devices and other products also comprise MicroPulse P3 Probe, a delivery device used in the cyclophotocoagulation procedure to treat various stages of glaucoma; EndoProbe, a fiber optic delivery device used for endophotocoagulation; G-Probe, a sterile single-use product used in procedures to treat medically and surgically uncontrolled glaucoma; DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears; GreenTip Soft Tip Cannula used to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FITCH SANFORDDirectorApr 22Option Exercise2.275,00011,35046,607Apr 25 06:51 PM
MOORE WILLIAM MChairman and CEOMar 16Option Exercise2.275,00011,350345,931Mar 17 06:57 PM
Steckel RonaldVP, OperationsMar 08Option Exercise3.996,25024,93875,125Mar 09 07:25 PM
Steckel RonaldVP, OperationsMar 08Sale10.4512,000125,40666,875Mar 09 07:25 PM
MOORE WILLIAM MChairman and CEONov 19Buy9.8310,00098,326290,931Nov 19 06:43 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerSep 25Buy7.025,00035,1001,250,000Sep 25 04:05 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerSep 24Buy6.9613,54294,2521,245,000Sep 25 04:05 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerSep 23Buy7.0933,500237,5151,231,458Sep 25 04:05 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerSep 10Buy6.978,25957,5651,197,958Sep 11 04:10 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerSep 09Buy6.893,60724,8521,189,699Sep 11 04:10 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerSep 04Buy6.835,20035,5161,186,092Sep 04 04:12 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerSep 03Buy6.832,70418,4681,180,892Sep 04 04:12 PM
Steckel RonaldVP, OperationsSep 02Option Exercise3.861,8757,23030,750Sep 03 06:10 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerSep 02Buy6.752,40016,2001,178,188Sep 04 04:12 PM
Steckel RonaldVP, OperationsSep 02Sale6.801,87512,75028,875Sep 03 06:10 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 21Buy7.188,85163,5501,175,788Aug 21 04:40 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 20Buy7.1610,30073,7481,166,937Aug 21 04:40 PM
Steckel RonaldVP, OperationsAug 19Option Exercise3.991,6846,71929,875Aug 20 05:36 PM
Mackaness James HCFO and COOAug 19Option Exercise4.311,8798,09846,931Aug 21 06:20 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 19Buy7.061,50010,5901,156,637Aug 21 04:40 PM
Mackaness James HCFO and COOAug 19Sale7.152,37316,96745,052Aug 21 06:20 PM
Steckel RonaldVP, OperationsAug 19Sale7.141,75112,49928,875Aug 20 05:36 PM
Mackaness James HCFO and COOAug 18Option Exercise4.312,0868,99146,517Aug 19 06:22 PM
Mackaness James HCFO and COOAug 18Sale7.102,62718,65844,531Aug 19 06:22 PM
Mackaness James HCFO and COOAug 17Option Exercise4.311,7797,66745,796Aug 19 06:22 PM
Mackaness James HCFO and COOAug 17Sale7.052,23515,75744,017Aug 19 06:22 PM
Mackaness James HCFO and COOAug 14Option Exercise4.312,2009,48245,761Aug 17 06:15 PM
Mackaness James HCFO and COOAug 14Sale7.052,76519,49343,531Aug 17 06:15 PM
Steckel RonaldVP, OperationsAug 14Sale7.001,0007,00028,942Aug 14 07:34 PM
Steckel RonaldVP, OperationsAug 13Option Exercise3.994001,59630,342Aug 14 07:34 PM
Mackaness James HCFO and COOAug 13Option Exercise4.314,00417,25747,000Aug 17 06:15 PM
Mackaness James HCFO and COOAug 13Sale6.955,00034,75042,996Aug 17 06:15 PM
Steckel RonaldVP, OperationsAug 13Sale7.004002,80029,942Aug 14 07:34 PM
Steckel RonaldVP, OperationsAug 12Sale7.005840629,942Aug 14 07:34 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 07Buy7.246,32445,7861,155,137Aug 07 04:55 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 06Buy6.5640,210263,7781,148,813Aug 07 04:55 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerAug 05Buy6.6345,000298,3501,108,603Aug 07 04:55 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerJul 24Buy6.9815,984111,5681,063,603Jul 27 05:29 PM
PARAGON ASSOCIATES & PARAGON A10% OwnerJul 23Buy7.0324,419171,6661,047,619Jul 27 05:29 PM
FITCH SANFORDDirectorJun 26Option Exercise6.193,75023,21339,094Jun 29 06:31 PM
Steckel RonaldVP, OperationsJun 17Option Exercise3.941,6666,56431,041Jun 18 06:46 PM
Steckel RonaldVP, OperationsJun 17Sale8.771,66614,60630,000Jun 18 06:46 PM
Mackaness James HCFO and COOMay 20Option Exercise0.902,0001,80044,000May 21 07:19 PM
Mackaness James HCFO and COOMay 20Sale9.802,00019,60942,000May 21 07:19 PM
Steckel RonaldVP, OperationsMay 18Option Exercise3.941,6676,56831,042May 19 07:29 PM
Steckel RonaldVP, OperationsMay 18Sale9.331,66715,54730,000May 19 07:29 PM